Prospective randomized multicenter adjuvant Dermatologic Cooperative Oncology Group trial of low-dose interferon Alfa-2b with or without a modified high-dose interferon Alfa-2b induction phase in patients with lymph node-negative melanoma

Saved in:

Bibliographic Details
Main Authors:	Hauschild, Axel (Author) , Weichenthal, Michael (Author) , Rass, Knuth (Author)
Other Authors:	Linse, Ruthild (Other) , Ulrich, Jens (Other) , Stadler, Rudolf (Other) , Volkenandt, Matthias (Other) , Grabbe, Stephan (Other) , Proske, Ulrike (Other) , Schadendorf, Dirk (Other) , Brockmeyer, Norbert (Other) , Vogt, Thomas (Other) , Rompel, Rainer (Other) , Kaufmann, Roland (Other) , Kaatz, Martin (Other) , Näher, Helmut (Other) , Mohr, Peter (Other) , Eigentler, Thomas (Other) , Livingstone, Elisabeth (Other) , Garbe, Claus (Other)
Format:	Article (Journal)
Language:	English
Published:	2009
In:	Journal of clinical oncology. [Englische Ausgabe] Year: 2009, Volume: 27, Issue: 21, Pages: 3496-3502
ISSN:	0732-183X
DOI:	10.1200/JCO.2008.21.3892
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/JCO.2008.21.3892
Author Notes:	Axel Hauschild, Michael Weichenthal, Knuth Rass, Ruthild Linse, Jens Ulrich, Rudolf Stadler,Matthias Volkenandt, Stephan Grabbe, Ulrike Proske, Dirk Schadendorf, Norbert Brockmeyer,Thomas Vogt, Rainer Rompel, Roland Kaufmann, Martin Kaatz, Helmut Näher, Peter Mohr,Thomas Eigentler, Elisabeth Livingstone, and Claus Garbe

Description
ISSN:	0732-183X
DOI:	10.1200/JCO.2008.21.3892

Similar Items